SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-010523
Filing Date
2017-02-23
Accepted
2017-02-23 10:14:08
Documents
1
Period of Report
2017-02-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v460261_8k.htm 8-K 22541
  Complete submission text file 0001144204-17-010523.txt   23695
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 17631085
SIC: 2835 In Vitro & In Vivo Diagnostic Substances